Navigation Links
ChanTest hires Chris Mathes as Chief Commercial Officer

CLEVELAND, Aug. 17, 2012 /PRNewswire/ -- Today ChanTest announces the hiring of Chris Mathes, Ph.D., M.B.A. to lead its business into a new era. Mathes starts September 1st as Chief Commercial Officer (CCO) and will oversee all sales, marketing and customer relations activities at ChanTest. He will also contribute to the forward looking and strategic guidance of ChanTest as a global player in the CRO industry.

(Photo: )

"Chris is a real ion channel guy," said Dr. Arthur "Buzz" Brown, CEO, President & Founder of ChanTest. "As CCO, he brings a unique mix of science and business to our company in order to make ChanTest's interface to the world even better."

Dr. Mathes has a Ph.D. in Neuroscience from UCLA and an MBA from Rutgers University. He has published several ion channel papers in peer reviewed journals over the past two decades.  In the last 10 years, Mathes has been a pioneer in the development and implementation of automated patch clamp systems for ion channel safety testing and drug discovery. 

"I'm really excited about this opportunity at ChanTest," Mathes said. "ChanTest is already the market leading ion channel CRO. My goal is to further enhance the brand and to expand the business.  I want to make sure that every pharmaceutical or biotech lab in the world accesses the ion channel and scientific expertise available at ChanTest."

About ChanTest Corporation (

ChanTest translates the most advanced Ion Channel, GPCR and Transporter technologies to provide safer, more effective medicines. By combining electrophysiology, molecular biology and cell culture including cell lines, stem cells and native cells ChanTest has developed biomarkers, reagents and services that greatly enhance drug discovery. The Company has alliances in which its technologies are integrated with medicinal, combinatorial and computational chemistry, animal models and clinical trials to provide modular or complete services along the drug development pathway. Since its inception in 1998, ChanTest has tested compounds for more than 500 global pharmaceutical and biotechnology companies. ChanTest's library of  ion channel cell lines, validated human stem cell-derived cardiomyocytes and  predictive nonclinical cardiac risk assessment program are  the most comprehensive available today. Because of ChanTest's seminal role in cardiac safety and its uncompromising commitment to quality, ChanTest has been named the "most trusted and most used fee-for-service provider" for ion channel screening in an independent survey for the past three years. ChanTest is based in Cleveland, Ohio. For more information, e-mail

CONTACT: Kate Siver, +1-216-332-1665,

SOURCE ChanTest Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Meridian Labs Hires Investment Bank to Explore Strategic Opportunities
2. Health Revenue Assurance Associates Hires Valerie Rinkle as Vice President of Revenue Integrity Informatics
3. CSS Health Technologies Hires Industry Leader as New Senior Vice President of Sales
4. NHD Hires Ron Cronin as Executive Director
5. Millstone Medical Outsourcing Hires New Vice President Quality
6. Zimmer Holdings Names Christopher Begley to Board of Directors
7. Doug Pepper appointed as Chief Financial Officer at Cardiac Science
8. ADVENTRX Announces Appointment Of Chief Medical Officer
9. Accelr8 Appoints Steve Reichling Chief Financial Officer
10. Nile Therapeutics Promotes Darlene Horton, M.D., to Chief Executive Officer and Director
11. Qforma Chief Technologist Honored as One of PharmaVOICE Magazines "100 Most Inspiring People in the Life Sciences"
Post Your Comments:
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... startling report released today, National Safety Council research shows ... plan to eliminate prescription opioid overdoses. Prescription Nation ... the worst drug crisis in recorded U.S. history, assigned a "Making ... , New Mexico , Tennessee ... states, three – Michigan , Missouri ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their highest five-star rating ... Millions of individuals in the United States and Canada wear eyeglasses. Once considered to ... correct vision and make a fashion statement. Even celebrities use glasses as a way ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from reveals that ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):